
|Articles|July 25, 2018
Novartis Partners with SHYFT
Advertisement
SHYFT Analytics announced that Novartis selected its Intelligent Platform for Life Sciences to support the commercialization of therapies in Europe.
Novartis will use the following SHYFT solutions:
- STRATA Data Platform to aggregate and manage a growing number of third party and proprietary commercial data sources
- LUMEN Insights Platform to deliver intuitively-designed analytics to drive the “next-best-actions” for commercial teams
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
3
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
4
Patients Avoid Care as Healthcare Costs Rise: Report
5





